Cislee 50 Injection
Marketer
Admac Pharma Ltd
Salt Composition
Cisplatin (50mg)
Overview Cislee 50 Injection
OvaTreat 50 Injection is a prescription medication indicated for the management of ovarian, cervical, and testicular cancers. Its mechanism of action involves inhibiting or decelerating cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Adhere strictly to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months to manifest; discontinue use only under medical supervision. Common side effects include injection site inflammation (pain, swelling, redness), nausea, and emesis. Ototoxicity (hearing impairment or damage) is a serious potential adverse effect, necessitating pre- and ongoing audiological assessments. This medication can induce leukopenia and thrombocytopenia, increasing infection risk. Regular blood tests monitoring hematological parameters, as well as renal, hepatic, and cardiac function, are mandatory. Prior to commencing treatment, disclose any history of renal impairment to your doctor, as the medication can impact kidney function. Drug interactions are possible; inform your healthcare provider of all concurrent medications. This injection is contraindicated during pregnancy and lactation. Male infertility is a potential consequence; consultation regarding sperm cryopreservation is recommended before treatment initiation.
Uses of Cislee 50 Injection
Cancers of the ovaries, cervix, and testes.
Major Benefits of Cislee 50 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cislee 50 Injection:
- Injection site reactions (pain, swelling, redness)
- Increased risk of infection
- Ear disorder
- Vomiting
- Nausea
- Decreased blood cells (red cells, white cells, and platelets)
- Renal impairment
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Kidney damage
- Hearing loss
- Ringing in ear
How to use Cislee 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Cislee 50 Injection works:
Cislee 50 Injection is an anticancer drug that disrupts the genetic structure (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Cislee 50 Injection is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cislee 50 Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Physician consultation is recommended.
Breast feedingUNSAFE
Administering Cislee 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Cislee 50 Injection may induce adverse reactions, potentially impairing driving capabilities. These reactions can include drowsiness and/or nausea, impacting safe operation of a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, Cislee 50 Injection requires careful administration, potentially necessitating dosage modification. Physician consultation is advised. Cislee 50 Injection is contraindicated in patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
Cislee 50 Injection appears to be safe for use in individuals with liver impairment. Existing evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Cislee 50 Injection :
Should you forget a scheduled Cislee 50 Injection, seek advice from your physician.
Facts to Know About Cislee 50 Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Addictive | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based antitumor agents |
3,018 People bought this recently